Premium
Long‐term follow‐up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia
Author(s) -
Chen Christine I.,
Paul Harminder,
Wang Trina,
Le Lisa W.,
Dave Nimisha,
Kukreti Vishal,
g Wei Ellen,
Lau Anthea,
Bergsagel Peter Leif,
Trudel Suzanne
Publication year - 2014
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12785
Subject(s) - lenalidomide , medicine , neutropenia , cytopenia , rituximab , febrile neutropenia , gastroenterology , phases of clinical research , multiple myeloma , oncology , toxicity , lymphoma , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom